Short Interest in ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Rises By 27.8%

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 17,000 shares, an increase of 27.8% from the March 15th total of 13,300 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average daily volume of 117,500 shares, the short-interest ratio is presently 0.1 days.

Large investors have recently modified their holdings of the stock. Orion Portfolio Solutions LLC acquired a new stake in shares of ImmunoPrecise Antibodies during the 4th quarter worth about $237,000. JPMorgan Chase & Co. acquired a new stake in shares of ImmunoPrecise Antibodies during the 4th quarter worth about $292,000. Jane Street Group LLC acquired a new stake in shares of ImmunoPrecise Antibodies during the 4th quarter worth about $610,000. Finally, Ingalls & Snyder LLC acquired a new stake in shares of ImmunoPrecise Antibodies during the 4th quarter worth about $5,927,000.

Shares of NASDAQ:IPA opened at $9.22 on Wednesday. The business’s 50-day simple moving average is $11.10. ImmunoPrecise Antibodies has a 12-month low of $2.68 and a 12-month high of $33.34.

Separately, Industrial Alliance Securities downgraded ImmunoPrecise Antibodies from a “buy” rating to a “hold” rating in a research report on Tuesday, February 9th.

ImmunoPrecise Antibodies Company Profile

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in the antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.

Recommended Story: Dividend Achievers

Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.